CLOSALIS 50 micrograms/0.5 mg/g, ointment tube, 60 g
Active ingredients: Betamethasone, Calcipotriol, Calcipotriene hydrate, Betamethasone dipropionate
Commercialized according to BDPMDispensing in France: Prescription only
Ointmenttube, 60 gcutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CLOSALIS 50 microgrammes/0,5 mg/g, pommade
- Pharmaceutical form
- pommade
- Route of administration
- cutanée
- Presentation description
- 1 tube(s) aluminium verni époxy-phénols de 60 g
- Marketing authorisation holder
- LABORATOIRES MEDGEN
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 14 May 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61853543CIP73026512CIP133400930265123Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BÉTAMÉTHASONEpommade | 0,50 mg · 1 g de pommade | FT |
| DIPROPIONATE DE BÉTAMÉTHASONEpommade | — | SA |
| CALCIPOTRIOLpommade | 50 microgrammes · 1 g de pommade | FT |
| CALCIPOTRIOL MONOHYDRATÉpommade | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.